Search Results 81-90 of 17120 for monoclonal antibody

  1. Small Bowel Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as pembrolizumab, may ... Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2.

  2. Publications - Mike M. Bierle, M.D. - Mayo Clinic

    ... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Yang J, Shin KM, Do A, Bierle ...

  3. Multiple sclerosis - Diagnosis and treatment - Mayo Clinic

    This treatment is a monoclonal antibody that decreases annual relapse rates and demonstrates MRI benefits. This medicine helps reduce relapses of MS by ...

  4. Ibritumomab (intravenous route) - Side effects & uses - Mayo Clinic

    Ibritumomab injection is a monoclonal antibody. It is used together with another monoclonal antibody (rituximab) and one radioactive medication (Y-90).

  5. Hodgkin Lymphoma (Hodgkin Disease) Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as ipilimumab and nivolumab, may interfere with the ability of cancer cells to grow and spread. Brentuximab vedotin is a combining ...

  6. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 featured. Featured News. Monoclonal antibody treatment ...

  7. Clinical trials - Oncology (Medical)

    Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

  8. Belimumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Belimumab injection is used to treat active, autoantibody ... It is a monoclonal antibody that changes the immune system to help control lupus symptoms.

  9. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Prior anti-cancer monoclonal antibody (mAb) =< 4 weeks prior to registration ...

  10. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types - Mayo Clinic

    ... monoclonal antibody, and compare them with clinical outcomes. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...